Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.

The Journal of pathology - 1 Sept 2010

Zhang Jun-Yi, Wang Yan, Zhang Di, Yang Zhi-Qiang, Dong Xin-Jun, Jiang Gui-Yang, Zhang Peng-Xin, Dai Shun-Dong, Dong Qian-Ze, Han Yang, Zhang Sheng, Cui Quan-Zhe, Wang En-Hua

Abstract excerpt

As a member of the catenin family, little is known about the clinical significance and possible mechanism of delta-catenin expression in numerous tumours. We examined the expression of delta-catenin by immunohistochemistry in 115 cases of non-small cell lung cancer (NSCLC) (including 65 cases with follow-up records and 50 cases with paired lymph node metastasis lesions). The mRNA and protein expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Catenins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Collagen

Share to Delta Catenin

Share to Drug Combinations

Share to Laminin

Share to Lymphatic Metastasis

Share to Proteoglycans

Source

Identifiers

PMID: 20593408
DOI: 10.1002/path.2742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.PMID 20593408Read ↗

Co-expression of delta-catenin and RhoA is significantly associated with a malignant lung cancer phenotype.Semantic proximity Read ↗

Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer.Semantic proximity Read ↗

β-Catenin Contributes to Lung Tumor Development Induced by EGFR MutationsSemantic proximity Read ↗

p120-Catenin Is Transcriptionally Downregulated by FOXC2 in Non–Small Cell Lung Cancer CellsSemantic proximity Read ↗

Upregulation of δ‐catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non‐small‐cell lung cancerSemantic proximity Read ↗

β-catenin inhibitors in cancer therapeutics: intricacies and way forwardSemantic proximity Read ↗

The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.Semantic proximity Read ↗

Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.Semantic proximity Read ↗

Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancerSemantic proximity Read ↗

The Expression Pattern of p120-Catenin is Associated With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

[Expressions of Axin and beta-catenin in non-small cell lung cancer].Semantic proximity Read ↗

Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.